The National Institutes of Health has partnered with two companies to evaluate agency facilities that produce sterile or infused medicines for clinical research use. NIH said Tuesday preliminary findings of the assessment identified quality
We use cookies to offer you a better browsing experience, analyze site traffic, personalize content, and serve targeted advertisements. Read about how we use cookies and how you can control them on our Privacy Policy. If you continue to use this site, you consent to our use of cookies.